Cryo-Cell International, Inc. (CCEL)
NYSEAMERICAN: CCEL · IEX Real-Time Price · USD
6.70
-0.38 (-5.37%)
Apr 16, 2024, 4:00 PM EDT - Market closed

Cryo-Cell International Statistics

Total Valuation

CCEL has a market cap or net worth of $55.52 million. The enterprise value is $66.10 million.

Market Cap 55.52M
Enterprise Value 66.10M

Important Dates

The last earnings date was Monday, April 15, 2024, after market close.

Earnings Date Apr 15, 2024
Ex-Dividend Date n/a

Share Statistics

CCEL has 8.29 million shares outstanding. The number of shares has decreased by -1.77% in one year.

Shares Outstanding 8.29M
Shares Change (YoY) -1.77%
Shares Change (QoQ) +1.05%
Owned by Insiders (%) 46.18%
Owned by Institutions (%) 10.57%
Float 4.36M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1.77
Forward PS 1.71
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 2.11
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.49

Current Ratio 0.49
Quick Ratio 0.40
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -12.42

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -14.90%
Return on Capital (ROIC) -1,154.12%
Revenue Per Employee $382,579
Profits Per Employee -$118,686
Employee Count 82
Asset Turnover 0.48
Inventory Turnover 1.08

Taxes

Income Tax -4.05M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +88.84% in the last 52 weeks. The beta is 0.55, so CCEL's price volatility has been lower than the market average.

Beta (1Y) 0.55
52-Week Price Change +88.84%
50-Day Moving Average 6.11
200-Day Moving Average 5.67
Relative Strength Index (RSI) 47.60
Average Volume (30 Days) 10,145

Short Selling Information

The latest short interest is 9,453, so 0.11% of the outstanding shares have been sold short.

Short Interest 9,453
Short Previous Month 9,397
Short % of Shares Out 0.11%
Short % of Float 0.22%
Short Ratio (days to cover) 1.22

Income Statement

In the last 12 months, CCEL had revenue of $31.37 million and -$9.73 million in losses. Loss per share was -$1.16.

Revenue 31.37M
Gross Profit 22.84M
Operating Income -14.06M
Pretax Income -13.78M
Net Income -9.73M
EBITDA -11.34M
EBIT -12.76M
Loss Per Share -$1.16
Full Income Statement

Balance Sheet

The company has $979,593 in cash and $11.56 million in debt, giving a net cash position of -$10.58 million or -$1.28 per share.

Cash & Cash Equivalents 979,593
Total Debt 11.56M
Net Cash -10.58M
Net Cash Per Share -$1.28
Equity / Book Value -10.34M
Book Value Per Share -1.25
Working Capital -9.92M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $6.92 million and capital expenditures -$6.92 million, giving a free cash flow of -$2,128.

Operating Cash Flow 6.92M
Capital Expenditures -6.92M
Free Cash Flow -2,128
FCF Per Share -$0.00
Full Cash Flow Statement

Margins

Gross margin is 72.79%, with operating and profit margins of -44.81% and -31.02%.

Gross Margin 72.79%
Operating Margin -44.81%
Pretax Margin -43.94%
Profit Margin -31.02%
EBITDA Margin -36.13%
EBIT Margin -40.67%
FCF Margin -0.01%

Dividends & Yields

CCEL does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth 1
Payout Ratio n/a
Buyback Yield 1.77%
Shareholder Yield 1.77%
Earnings Yield -17.53%
FCF Yield -0.00%
Dividend Details

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

CCEL has an Altman Z-Score of -0.6 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -0.6
Piotroski F-Score 4